During the past decade, Ministerio da Saude - Instituto Nacional do Cancer conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ministerio da Saude - Instituto Nacional do Cancer" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ministerio da Saude - Instituto Nacional do Cancer" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Multiple Myeloma" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Chronic Graft Versus Host Disease" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Ministerio da Saude - Instituto Nacional do Cancer" in a lesser frequency.

Most popular intervention types in "Ministerio da Saude - Instituto Nacional do Cancer" are "Drug" (9 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (3 trials), "Amivantamab" (2 trials), "Niraparib" (2 trials), "Placebo" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ministerio da Saude - Instituto Nacional do Cancer" are 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ministerio da Saude - Instituto Nacional do Cancer". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Ministerio da Saude - Instituto Nacional do Cancer, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ministerio da Saude - Instituto Nacional do Cancer, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".